A novel point of care test for sputum sample stratification prior to the quantitative measurement of active neutrophil elastase

D. McCafferty (Belfast, United Kingdom), K. Moffitt (Belfast, United Kingdom), C. Robb (Belfast, United Kingdom), D. Ramsay (Belfast, United Kingdom), A. Kennedy (Belfast, United Kingdom), T. Ferguson (Belfast, United Kingdom), B. Walker (Belfast, United Kingdom)

Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Session: Clinical and functional monitoring in airway disease
Session type: Thematic Poster
Number: 4450
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. McCafferty (Belfast, United Kingdom), K. Moffitt (Belfast, United Kingdom), C. Robb (Belfast, United Kingdom), D. Ramsay (Belfast, United Kingdom), A. Kennedy (Belfast, United Kingdom), T. Ferguson (Belfast, United Kingdom), B. Walker (Belfast, United Kingdom). A novel point of care test for sputum sample stratification prior to the quantitative measurement of active neutrophil elastase. 4450

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The adaptation of a point of care test for the quantitative determination of active neutrophil elastase in sputum
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


Investigating optimal sputum processing methods for active neutrophil elastase quantification
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017



An innovative high sensitivity tool for active neutrophil elastase quantification
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021


A rapid method to increase the clinical use of sputum inflammatory cells
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017




A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019



Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021


A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019
Year: 2019



IP-10 measurement using a point of care test for the diagnosis of active tuberculosis
Source: Annual Congress 2011 - What is new in tuberculosis immunodiagnosis?
Year: 2011

A study to assess the magnitude and reasons of initial default among sputum smear positive pulmonary tuberculosis patients
Source: Annual Congress 2010 - Tuberculosis control
Year: 2010

Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019

How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Comparison of different sputum examination methods to determine time for discontinuation of respiratory isolation for tuberculosis patients
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II
Year: 2008


Comparative study on the diagnostic value of a modern gamma-interferon test applied in blood and bronchoalveolar lavage in children suspected of tuberculosis - final results
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020

Applying sputum as a diagnostic tool in pneumonia - limited yield, minimal impact on treatment decisions
Source: Eur Respir J 2001; 18: Suppl. 33, 502s
Year: 2001

The six-gene expression signature in whole sampled sputum provides clinically feasible inflammatory phenotyping of asthma
Source: ERJ Open Res, 6 (1) 00280-2019; 10.1183/23120541.00280-2019
Year: 2020



Sputum induction in asthmatic children: safety in children and feasibility of new methods of monitoring inflammation in sputum samples
Source: Eur Respir J 2006; 28: Suppl. 50, 259s
Year: 2006

A comparison of sputum induction methods
Source: Eur Respir J 2002; 20: Suppl. 38, 542s
Year: 2002

Comparison of the diagnostic value of immunological test, applied to two types of biological fluids - venous blood and bronchoalveolar lavage in children with tuberculosis
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018

What is the value of multiple sputum cultures in the routine investigation of community acquired pneumonia (CAP)?
Source: Eur Respir J 2003; 22: Suppl. 45, 151s
Year: 2003